Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

A Simple Nudge Moves the Needle on Statin Prescribing

Michael O'Riordan

December 02, 2022

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

Todd Neale

November 06, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Todd Neale

September 26, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

Advertisement

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

December 2022 News Roundup

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Reduction in BP Drives Treatment Preference for Hypertensive Patients

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

A Simple Nudge Moves the Needle on Statin Prescribing

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

October 2022 News Roundup

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Most Patient-Reported Outcome Measures in CVD Fall Short

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

CV Care Around Noncardiac Surgery: New ESC Guidelines

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content